VentriJect: Prioritising VO2 Max Testing
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
VentriJect: Prioritising VO2 Max Testing
-
Narrated by:
-
By:
In this episode of the Medtech Ventures podcast, Craig Townsend interviews Kasper Sørensen, CTO and co-founder of VentriJect, about the Seismofit, technology for estimating VO2 max.
They discuss Kasper's journey from academia to entrepreneurship, the challenges of developing a medical device, navigating regulatory landscapes, and the importance of VO2 max as a vital sign monitor.
The conversation also explores the future of cardiorespiratory health and AI. Kasper shares valuable insights for aspiring entrepreneurs, emphasizing the importance of pursuing good ideas.
Listen or download our podcast bi-weekly on Thursdays.
Follow Craig on LinkedIn.
adbl_web_anon_alc_button_suppression_t1
No reviews yet